BDRX

Biodexa Pharmaceuticals
BDRX

$0.79
3.13%

Market Cap: 7.2M

 

About: Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Employees: 16

0
Funds holding %
of 6,702 funds
Analysts bullish %
0
News positive %
of 6 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

200% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 0

0.05% less ownership

Funds ownership: 0.07% [Q4 2023] → 0.02% (-0.05%) [Q1 2024]

29% less funds holding

Funds holding: 7 [Q4 2023] → 5 (-2) [Q1 2024]

82% less capital invested

Capital invested by funds: $169K [Q4 2023] → $31.2K (-$138K) [Q1 2024]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Research analyst outlook

1 Wall Street Analyst provided 1 year price forecasts over the past 6 months

Low target
$8
907%
upside
Avg. target
$8
907%
upside
High target
$8
907%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Ladenburg Thalmann
Aydin Huseynov
907%upside
$8
Buy
Initiated
8 Feb 2024

Financial journalist opinion

Based on 6 articles about BDRX published over the past 30 days